Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xolair (Omalizumab) in Peanut-Allergic Subjects from Study Q2788g (TOPS)
NCT00382148Phase 2Completed
- Sponsor
- Genentech
- Start
- Nov 2006
- Primary completion
- Jun 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of omalizumab in Peanut allergy, sponsored by Genentech. Started Nov 2006; status: completed.
02
Drugs
omalizumab
03
Conditions
Peanut allergy
Beyond the preview
Go deeper on NCT00382148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00382148.